Weighted analysis of 2′-fucosyllactose, 3-fucosyllactose, lacto-N-tetraose, 3′-sialyllactose, and 6′-sialyllactose concentrations in human milk

被引:12
作者
Conze, Dietrich B. [1 ]
Kruger, Claire L. [1 ]
Symonds, Jennifer M. [1 ]
Lodder, Robert [2 ]
Schoenknecht, Yannik B. [3 ]
Ho, Manki [3 ]
Derya, Sami M. [3 ]
Parkot, Julia [3 ]
Parschat, Katja [3 ]
机构
[1] Spherix Consulting Grp Inc, Rockville, MD 20895 USA
[2] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
[3] Chr Hansen HMO GmbH, Maarweg 32, D-53619 Rheinbreitbach, Germany
关键词
Human milk oligosaccharides; Systematic review; Random sampling; 2 '-Fucosyllactose; 3-Fucosyllactose; Lacto-N-tetraose; 3 '-Sialyllactose; 6 '-Sialyllactose; PERFORMANCE LIQUID-CHROMATOGRAPHY; BREAST-FED INFANTS; CAPILLARY-ELECTROPHORESIS; NEUTRAL OLIGOSACCHARIDES; SIALYLATED OLIGOSACCHARIDES; ACIDIC OLIGOSACCHARIDES; ELECTROSPRAY-IONIZATION; MICROBIOTA COMPOSITION; ABSOLUTE QUANTITATION; COMPOSITION DIFFERS;
D O I
10.1016/j.fct.2022.112877
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Over 150 human milk oligosaccharides (HMOs) have been identified and their concentrations in human milk vary depending on Secretor and Lewis blood group status, environmental and geographical factors, lactation stage, gestational period, and maternal health. Quantitation of HMOs in human milk has been the focus of numerous studies, however, comprehensive and weighted statistical analyses of their levels in human milk are lacking. Therefore, weighted means, standard deviations, medians, interquartile ranges, and 90th percentiles for 2 & PRIME;-fucosyllactose (2 & PRIME;-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3 & PRIME;-sialyllactose (3 & PRIME;-SL) and 6 & PRIME;-sia-lyllactose (6 & PRIME;-SL) were calculated using random sampling and the levels of these HMOs in human milk reported in the literature. Probability distributions of the reported levels were also constructed. Although the levels reported in the published studies varied, the weighted means for 2 & PRIME;-FL, 3-FL, LNT, 3 & PRIME;-SL, and 6 & PRIME;-SL were calculated to be 2.58, 0.57, 0.94, 0.28, and 0.39 g/L, respectively, which are consistent with those that have been previously determined in other systematic analyses. Likely due to the use of weighting, the 90th percentiles were greater than the 95% confidence limits that have been previously calculated. Our study therefore provides accurate and important statistical data to help support the level of appropriate HMO supplementation in infant formula.
引用
收藏
页数:10
相关论文
共 147 条
[1]   Human milk oligosaccharide categories define the microbiota composition in human colostrum [J].
Aakko, J. ;
Kumar, H. ;
Rautava, S. ;
Wise, A. ;
Autran, C. ;
Bode, L. ;
Isolauri, E. ;
Salminen, S. .
BENEFICIAL MICROBES, 2017, 8 (04) :563-567
[2]   Safety of lacto-N-neotetraose as a novel food ingredient pursuant to Regulation (EC) No 258/97 [J].
Agostoni, Carlo ;
Canani, Roberto Berni ;
Fairweather-Tait, Susan ;
Heinonen, Marina ;
Korhonen, Hannu ;
La Vieille, Sebastien ;
Marchelli, Rosangela ;
Martin, Ambroise ;
Naska, Androniki ;
Neuhaeuser-Berthold, Monika ;
Nowicka, Grazyna ;
Sanz, Yolanda ;
Siani, Alfonso ;
Sjoedin, Anders ;
Stern, Martin ;
Strain, Sean ;
Tetens, Inge ;
Tome, Daniel ;
Turck, Dominique ;
Verhagen, Hans .
EFSA JOURNAL, 2015, 13 (07)
[3]   Occurrence of oligosaccharides in feces of breast-fed babies in their first six months of life and the corresponding breast milk [J].
Albrecht, Simone ;
Schols, Henk A. ;
van den Heuvel, Ellen G. H. M. ;
Voragen, Alphons G. J. ;
Gruppen, Harry .
CARBOHYDRATE RESEARCH, 2011, 346 (16) :2540-2550
[4]   CE-LIF-MSn profiling of oligosaccharides in human milk and feces of breast-fed babies [J].
Albrecht, Simone ;
Schols, Henk A. ;
van den Heuvel, Ellen G. H. M. ;
Voragen, Alphons G. J. ;
Gruppen, Harry .
ELECTROPHORESIS, 2010, 31 (07) :1264-1273
[5]   Associations between human milk oligosaccharides and infant body composition in the first 6 mo of life [J].
Alderete, Tanya L. ;
Autran, Chloe ;
Brekke, Benjamin E. ;
Knight, Rob ;
Bode, Lars ;
Goran, Michael I. ;
Fields, David A. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2015, 102 (06) :1381-1388
[6]   Perspectives on How FDA Assesses Exposure to Food Additives When Evaluating Their Safety: Workshop Proceedings [J].
Alger, Heather M. ;
Maffini, Maricel V. ;
Kulkarni, Neesha R. ;
Bongard, Erin D. ;
Neltner, Thomas .
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, 2013, 12 (01) :90-119
[7]  
[Anonymous], 2017, [No title captured]
[8]  
[Anonymous], Commission Implementing Decision 2012/506/EU of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/ EC of the European Parliament and of the Council
[9]   Variation of major neutral oligosaccharides levels in human colostrum [J].
Asakuma, S. ;
Urashima, T. ;
Akahori, M. ;
Obayashi, H. ;
Nakamura, T. ;
Kimura, K. ;
Watanabe, Y. ;
Arai, I. ;
Sanai, Y. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (04) :488-494
[10]   Sialyl oligosaccharides of human colostrum: Changes in concentration during the first three days of lactation [J].
Asakuma, Sadaki ;
Akahori, Maiko ;
Kimura, Kazumasa ;
Watanabe, Yoko ;
Nakamura, Tadashi ;
Tsunemi, Makoto ;
Arai, Ikichi ;
Sanai, Yasuhiro ;
Urashima, Tadasu .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2007, 71 (06) :1447-1451